LINCOLN, NEBRASKA (RFD NEWS) — A new vaccine is showing promise in combating Highly Pathogenic Avian Influenza (HPAI), with testing currently underway in mice and dairy calves. The promising research is led by the University of Nebraska–Lincoln (UNL).
UNL Professor of Biological Sciences Eric Weaver joined us on Tuesday’s Market Day Report to provide an update on the development.
In his interview with RFD News, Weaver discussed details of the vaccine and the results from early testing. He also outlined the next steps in the research process as work continues.
Finally, Weaver explained the potential impacts this vaccine could have on the livestock industry as it continues to battle HPAI.
Related Stories
High Path Avian Influenza has significantly impacted poultry and egg prices recently. Will consumers face the same pressures this Thanksgiving?
In Texas, there are about 800 contract broiler and turkey farms. RFD NEWS Correspondent Tammi Arender had the chance to meet with Jerry Moody, who has been in the chicken business all of his life.
The U.S. government will give pharmaceutical company Moderna $176 million for a High-Path Avian Flu vaccine, Reuters reports.
